Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
4.515
-0.225 (-4.75%)
At close: Nov 14, 2025, 4:00 PM EST
4.590
+0.075 (1.66%)
After-hours: Nov 14, 2025, 6:54 PM EST
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $7.01 million as of November 14, 2025. Its market cap has decreased by -77.30% in one year.
Market Cap
7.01M
Enterprise Value
1.10M
1-Year Change
-77.30%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $7.01M, a decrease of -87.76%. That is a compound annual growth rate of -38.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 7.01M | -49.05% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |